本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

3.39
+0.19175.99%
成交量:975.21萬
成交額:3,235.64萬
市值:18.15億
市盈率:-3.32
高:3.43
開:3.20
低:3.18
收:3.20
52周最高:7.18
52周最低:2.77
股本:5.35億
流通股本:5.22億
量比:0.93
換手率:1.87%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
淨資產收益率:-56.58%
總資產收益率:-27.33%
市淨率:1.98
市盈率(LYR):-2.35

資料載入中...

2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/13

SEC問詢函

Form CORRESP - Correspondence
2024/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/07

重要事件披露

Form 8-K - Current report
2024/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities